Alan Ezekowitz - 13 Jun 2025 Form 4 Insider Report for Organon & Co. (OGN)

Role
Director
Signature
/s/ Tarnetta V. Jones, as Attorney-in-Fact for Alan Ezekowitz
Issuer symbol
OGN
Transactions as of
13 Jun 2025
Net transactions value
+$240,000
Form type
4
Filing time
16 Jun 2025, 17:21:01 UTC
Previous filing
10 Mar 2025
Next filing
20 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Ezekowitz Alan Director C/O ORGANON & CO., 30 HUDSON STREET, FLOOR 33, JERSEY CITY /s/ Tarnetta V. Jones, as Attorney-in-Fact for Alan Ezekowitz 16 Jun 2025 0001780209

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OGN Phantom Stock Award $240,000 +23,904 +62% $10.04 62,703 13 Jun 2025 Common Stock 23,904 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each phantom stock unit is an economic equivalent of one share of Organon & Co. ("Organon") common stock, or 1-for-1.
F2 Phantom stock units are granted under the Organon Non-Employee Director Savings Plan (the "Plan") and are payable in cash upon settlement after the reporting person's termination of service as a director pursuant to the terms of the Plan.
F3 Holdings include phantom stock units acquired in dividend reinvestment transactions on June 13, 2024, September 12, 2024, December 12, 2024, March 13, 2025 and June 12, 2025.